Enhanced lymph node dissection improves outcomes in gastric adenocarcinoma patients
Findings indicate that lymph node dissection (LND) during upfront gastrectomy significantly impacts prognostic outcomes for gastric adenocarcinoma (GAC) patients. The study recommends total lymph node (TLN) counts of ≥18 for detecting positive nodes and ≥23 for identifying N3 status. Furthermore, a negative lymph node count (NLN) >9 correlates with better survival in N+ GAC patients, requiring a TLN ≥20 for effective staging. Ultimately, D2 dissection is endorsed as superior for LND effectiveness.
An enhanced-recovery pathway after endoscopic removal of small upper gastrointestinal lesions shortened hospital stays without increasing complications.
